bacterial clearance in a Galleria mellonella larva infection model. Finally, our experiments revealed that patients infected with B. cenocepacia, B. multivorans, B. pseudomallei, or B. mallei develop O-glycan-specific antibodies. Together, these results highlight the importance of general protein O-glycosylation in the biology of the Burkholderia genus and its potential as a target for inhibition or immunotherapy approaches to control Burkholderia infections. _____________________________________
The Burkholderia genus encompasses widespread environmental Gram-negative bacteria adapted to survive in the rhizosphere and fresh water (1, 2) . Some Burkholderia species including those in the B. cepacia complex, B. mallei, and B. pseudomallei cause life-threatening infections in humans. The B. cepacia complex encompasses over 18 closely related species typically infecting patients with cystic fibrosis; some of these species, especially B. cenocepacia, cause the fatal cepacia syndrome (3) . B. mallei and B. pseudomallei are potential biological warfare agents (4) , which cause glanders and melioidosis, respectively. B. mallei typically infects horses, donkeys and mules, which are the primary reservoir of this mammalianadapted pathogen that evolved from the environmental pathogen B. pseudomallei through gene loss (5) . Glanders is characterized by pneumonia, often with systemic sepsis, or by skin and lymph node disease (Farcy). B. pseudomallei is endemic to southeast Asia and northern Australia and is being increasingly recognized in the tropics globally, including Africa and the Americas (6) (7) (8) . Melioidosis can be acquired by inhalation or through skin abrasions or ingestion, causing a wide spectrum of symptoms including pneumonia and rapidly progressive systemic sepsis (7) . B. pseudomallei can also remain latent and asymptomatic, with subsequent activation and presentation as melioidosis many years after initial exposure (9) . Antibiotic treatment of Burkholderia-related infections is difficult due the high-level intrinsic multidrug resistance of these bacteria (10) , and there are no clinically approved vaccines for either melioidosis or glanders prevention in humans or animals (11) .
Protein glycosylation is a posttranslational modification that modulates protein physicochemical properties and functions, and is common in bacteria (12) (13) (14) . Glycans may be attached to the amide nitrogen of asparagine residues of a polypeptide (Nglycosylation) or to hydroxyl oxygen of serine or threonine residues (O-glycosylation) (15) . In other cases, α-mannopyranose can be linked to tryptophan via a carbon-carbon link (Cmannosylation) (16) and glycans can also be attached to the sulfur of cysteine (S-linked glycosylation) (17) . The N-linked general protein glycosylation pathway in bacteria was first elucidated in Campylobacter jejuni (18, 19) .
This system includes the oligosaccharyltransferase (OTase) PglB (20) , which is homologous to the eukaryotic Stt3, the catalytic subunit of the OTase complex responsible for N-glycosylation in the lumen of the endoplasmic reticulum.
O-glycosylation systems have also been noted in many different bacteria (12) (13) (14) (15) . The O-glycosylation of at least 23 proteins with an uncharacterized predicted trisaccharide glycan, mediated by the OTase PglL, was previously identified in B. cenocepacia (21) . However, the genes and gene products for the B. cenocepacia glycosylation machinery and the chemical structure of the glycan moiety were not elucidated. In this study, we report the identification of the Burkholderia Oglycosylation (ogc) cluster, which includes genes in chromosome 1 of B. cenocepacia (BCAL3114 to BCAL3118) encoding the enzymes required for the stepwise assembly of the lipid-linked O-glycan in the cytoplasm and its flipping across the inner membrane. We also discovered these genes are present in all species of Burkholderia and confirm biochemically the presence of O-linked proteins in several species of Burkholderia, suggesting protein Oglycosylation is a conserved feature of this genus. To elucidate the biosynthesis of the Olinked glycan, we generated knockout mutants in the ogc genes characterizing their effect on glycosylation and assessing the function of the epimerase within this cluster. From these studies we have confirmed the predicted role of the ogc genes and also established the structure of the trisaccharide glycan. We also show that O-glycosylation is required for bacterial fitness in vitro and survival in a larvae infection model. Lastly, we demonstrate that individuals previously infected with B. cenocepacia, B. multivorans, B. pseudomallei and B. mallei develop anti-O-glycan serum antibodies, suggesting Burkholderia glycoproteins display a common epitope perceived by the human immune system.
RESULTS
A predicted B. cenocepacia Oglycosylation gene cluster is conserved in the Burkholderia genus. Previous work identified PglL (BCAL0960) as the OTase catalyzing the addition of an uncharacterized trisaccharide Oglycan to least 23 B. cenocepacia proteins (21) . In OTase-dependent glycosylation pathways, the lipid-linked glycan precursor is assembled on the cytoplasmic side of the membrane, translocated across the membrane, and then transferred onto acceptor proteins at the periplasmic side (22) . We therefore hypothesized that at least four genes encoding a phosphoglycosyl transferase (initiating enzyme that mediates the synthesis of a lipidlinked sugar) (23, 24) , two additional glycosyltransferases, and a flippase protein would be required for the synthesis and translocation of a B. cenocepacia lipid-linked trisaccharide glycan (22, 24) . The chromosome 1 of B. cenocepacia has a putative five-gene operon flanked by the O-antigen synthesis cluster and lipid A-core biosynthesis genes (25) (Fig. 1A) , which could be involved in protein glycosylation. These genes were previously annotated, according to their predicted functions, as wecA (BCAL3118, phosphoglycosyl transferase), galE (BCAL3117, UDP-glucose epimerase), wbxA and wbxB (BCAL3116 and BCAL3115, glycosyltransferases, GT2 family forming bglyosidic bonds and GT4 family forming aglyosidic bonds, respectively) and wzx (BCAL3114, flippase) (25) . This putative operon was herein renamed ogc (for Oglycosylation) (see below). The last ogc gene, BCAL3118, which encodes a predicted UDP-N-acetylhexosamine-1-P transferase homologous to WecA-like initiating enzymes for O-antigen synthesis, was renamed ogcI (for initiating transferase). The immediately upstream gene, BCAL3117, encodes a protein similar to UDP-glucose-4-epimerases of the NAD-dependent epimerase/dehydratase family, and it was renamed ogcE. The two predicted glycosyltransferase encoding genes, BCAL3115 and BCAL3116, were renamed ogcA and ogcB, respectively. BCAL3114, renamed ogcX, encodes a predicted flippase protein belonging to the Wzx-like polysaccharide transporter family. Therefore, the ogc cluster encodes proteins whose predicted functions fit well with the required enzymatic activities to assemble the lipidlinked trisaccharide glycan for protein glycosylation, according to the model depicted in Fig. 1B .
Using the SyntTax web server (26) and the Burkholderia genome database (27) , we discovered the ogc cluster is conserved in the majority of Burkholderia and Paraburkholderia species whose genomes have been sequenced (Fig. 1C ). Most species retain the five-gene cluster with the genes arranged as in B. cenocepacia. In a reduced number of species, ogcXABE remain together while ogcI appears as a single monocistronic gene separated from the cluster by a variable number of genes depending on the species examined ( Fig. 1C ). In P. rhizoxinica, ogcB is present as a monocistronic gene while the rest of the genes, ogcXAEI, form a putative operon (Fig. 1C) . Therefore, the ogc cluster appears to be a highly conserved loci encoding the minimal set of gene products to produce the trisaccharide O-linked glycan observed in B. cenocepacia.
A deletion mutant of the ogc cluster cannot glycosylate proteins. To validate the ogc cluster's role in protein glycosylation, we constructed an unmarked deletion mutant (∆ogc) in the B. cenocepacia strain K56-2, and a ∆pglL mutant as a control. We also generated the individual unmarked, non-polar deletion mutants ∆ogcX, ∆ogcI, ∆ogcAB, and ∆ogcE. In parallel, we constructed recombinant plasmids expressing His-tagged fusion forms of BCAL2640 and the DsbA1 protein from Neisseria meningitidis. BCAL2640 is a native glycosylated protein in B. cenocepacia, while the heterologously expressed DsbA1 is glycosylated by PglL (21) and also by several different OTases (28) . Expression of BCAL2640 and DsbA1 was examined in the K56-2 parental strain and its isogenic ∆ogc and ∆pglL mutants. The purified BCAL2640 polypeptide obtained from ∆ogc and ∆pglL had increased relative mobility compared to that obtained from the parental strain, suggesting loss of glycosylation ( Fig. 1D, left panel) . Similarly, examination of DsbA1 mobility by immunoblot with anti-His tag antibodies also revealed DsbA1 polypeptides of lower apparent mass in samples purified from ∆ogc and ∆pglL, as well as from ∆ogcX, ∆ogcI, ∆ogcAB, and ∆ogcE mutants ( Fig. 1D , right panel). Conversely, no difference in protein mobility was observed in DsbA1 expressed in an Oantigen synthesis deletion mutant ΔBCAL3119-BCAL3131, ruling out any contribution of the O antigen genes to protein glycosylation ( Fig 1D, right panel) .
To directly monitor the glycosylation status of purified BCAL2640 expressed in strains K56-2, ∆ogc and ∆pglL, the purified protein was digested with trypsin, and analyzed by liquid chromatography-mass spectrometry (LC-MS). The trypsin-derived BCAL2640 peptide 152 YAPPPAAVPVAATSGAQGGAAAAAAP AGTKPANAPR 187 , previously shown to be glycosylated (at the underlined serine residue) (21) , was readily observable. Tandem mass spectrometry (MS/MS) and fragmentation by collision-induced dissociation (CID) confirms the peptide is modified with at least two glycans corresponding to HexNAc-HexNAc-262 ( Fig.  2A) and HexNAc-HexNAc-Hex ( Fig. 2B ), while higher-energy collisional dissociation (HCD) fragmentation confirmed the peptide sequence (Fig. 2C ). The glycosylated form of this peptide was 15-fold more abundant than the unglycosylated form, indicating the majority of BCAL2640 was glycosylated ( Fig.  2D ). In contrast, this glycopeptide was absent in the purified protein obtained from ΔpglL or Δogc mutants ( Fig. 2e and f). Therefore, deletion of the ogc cluster causes the same defect in protein glycosylation as the loss of the OTase PglL, demonstrating it contains the genes encoding functions for the synthesis and assembly of the protein glycan.
Structural characterization of the Oglycan. To determine the structure of the B. cenocepacia O-glycan, glycopeptides modified with the trisaccharide were generated from glycosylated DsbA1 by digestion with proteinase K and enriched by size exclusion chromatography. This glycopeptide fraction was identified by nuclear magnetic resonance (NMR) spectroscopy analysis by both homoand heteronuclear two-dimensional NMR experiments ( Fig. 3A and Table S1 ). The heteronuclear single quantum coherence (HSQC) spectrum ( Fig. 3B ) showed three main anomeric signals with 1 H/ 13 C values at 5.07/94.5, 4.63/101.7, and 4.45/106.3 ppm ( Fig. 3A) , each labeled with a capital letter. For the A spin system, total correlation spectroscopy (TOCSY) displayed three correlations that connected H-1 up to H-4 ( Fig.  3c and Table S1 ). The attribution of these densities to the right proton in the sequence was inferred by analyzing the homonuclear correlation (COSY) spectrum, while the position of H-5 was identified by the H-4/H-5 correlation in the transverse rotating-frame Overhauser enhancement (T-ROESY) spectrum, which in turn defined the position of the two H-6 protons at 3.76 ppm. These results, together with those derived from the HSQC spectrum ( Fig. 3B ) and the H-2/C-2 values (4.38/51.0 ppm) along with the presence of an acetyl group in the proton spectrum, indicated that A was N-acetylgalactosamine. The 3 JH1,H2 value (3.3 Hz) pointed to a α-configuration for the anomeric centre. In addition, the downfield displacement of C-3 (79.1 ppm) with respect to the standard value (72.3 ppm) (29) indicated a substitution at this position.
For B and C residues, their 3 JH1,H2 values (8.4 and 8.0 Hz, respectively) disclosed their β configuration at the anomeric center. Using the same approach as described for residue A, residue B was identified as Nacetylgalactosamine (H-2/C-2 values at 4.11/52.0 ppm) and residue C as galactose (H2/C-2 values at 3.51/71.6 ppm). The comparison of the carbon chemical shifts of these two residues with those taken as reference (29) showed that C-3 of B (75.8 ppm) and C-6 of C (64.4 ppm) were shifted downfield with respect to the standard values (72.3 and 62.0 ppm, respectively), suggesting the presence of a substitution at these positions. The sequence of the three units was inferred by NOE contacts found in the T-ROESY spectrum among H-1 of A and both H-3 and H-4 of B, and H-1 of C with H-3 of A ( Fig. 3c ). Therefore, combining data from the nuclear Overhauser effects with the 13 C chemical shift displacement observed allowed us to build the sequence C-(1®3)-A-(1®3)-B. Importantly, H-1 of B did not correlate with any sugar-related signal, but only with protons related to the peptide moiety, for which we conclude the glycan structure is: β-Gal-(1®3)-α-GalNAc-(1®3)-β-GalNAc-(1®) directly linked to the protein (Fig. 3B ).
The T-ROESY spectrum did not contain crosspeaks connecting to any of the two H-6 of C to the substituent at O-6, but the type of chemical displacement of C-6 and C-5, along with the 1 H chemical shift of both H-6s, suggested the presence of an acyl substituent that was consistent with a succinylated hexose residue, observed as a mass of 262 Da by MS analysis, but remains to be structurally identified by NMR.
Dual role of OgcE in protein glycosylation and O-antigen synthesis. The predicted OgcE epimerase ( Fig. 1A ) could be required for the synthesis of UDP-GalNAc, UDP-Gal or both, which are the expected precursors for the assembly of the trisaccharide glycan. However, the O antigen in B. cenocepacia K56-2 is composed of a GalNAc-GalNAc-Rha repeating unit (25) , suggesting UDP-GalNAc is a common precursor for both O-antigen and protein glycan trisaccharide synthesis in this strain. To determine if OgcE is also required for O-antigen synthesis, we examined the lipopolysaccharide (LPS) profile of K56-2, ∆pglL, ∆ogc, and various deletion mutants in ogc genes. Only the ∆ogc and ∆ogcE mutants produced truncated O antigen, as indicated by a strong band migrating above the band corresponding to lipid A-core and the loss of bands corresponding to polymeric O antigen (Fig. 4A ). The O antigen in B. cenocepacia K56-2 is synthesized via the ABC export pathway (25, 30) . This requires an adaptor sugar, bound to undecaprenyl-PP, to which the repeating O-antigen units are attached, and this sugar in K56-2 is QuiNAc (31) . Therefore, the truncated O-antigen band, in the absence of UDP-GalNAc due to the loss of ogcE (Fig. 4A , asterisk), was interpreted as lipid A-core plus Rha-QuiNAc disaccharide. We have previously shown that a similar band appears in a GalNAc transferase mutant (25) . Complementation of ∆ogc with a plasmid expressing OgcE restored full O-antigen synthesis ( Fig. 4A ), but did not restore protein glycosylation ( Fig. 4B ). Therefore, OgcE (BCAL3117) participates in both the synthesis of O antigen and the protein glycan ( Fig. 4A and B ), while the remaining ogc genes are not involved in O-antigen synthesis.
OgcE is a UDP-Glc and UDP-GlcNAc epimerase. To elucidate the biochemical function of OgcE, we examined its enzymatic activity by capillary electrophoresis. Purified OgcE showed C4 epimerase activity on UDP-Gal and UDP-Glc ( Fig. 5A and C), reaching a final equilibrium of 79 % UDP-Glc and 21% UDP-Gal, irrespective of the starting substrate. OgcE also had C4 epimerase activity on UDP-GalNAc and UDP-GlcNAc ( Fig 5B and D) , reaching a final equilibrium of 68 % UDP-GlcNAc and 32 % UDP-GalNAc with either substrate. Identical results were obtained with both NAD + ( Fig. 5A and B) and NADP + ( Fig.  5C and D), suggesting the enzyme does not use any of these exogenously supplied cofactors. This conclusion is further supported by the unaltered amount of input cofactor after catalysis, the lack of release of reduced NADP + , and because catalysis can also occur in the absence of any cofactor (Fig. S1 , top two traces). A small amount of NADH was observed in all enzyme-containing reactions irrespective of the type of cofactor exogenously added, but no NADPH was released. Since the NADH appearance occurs irrespective of the type of added substrate or exogenous cofactor and is not proportional to the amount of catalysis, we surmised that the detected NADH was released by the enzyme. Indeed, release of NADH was also observed in control reactions performed without substrate (Fig. S1 , bottom trace). This suggests the OgcE preferentially binds NAD + over NAPH during overexpression in E. coli and explains why the bound cofactor alleviates the need for any exogenous cofactor. The release may occur due to progressive unfolding of the enzyme during lengthy incubations at 37 °C. To assess which type of substrate is most efficiently catalyzed, reactions were performed with serial dilutions of enzyme on UDP-Gal and UDP-GalNAc. These substrates were selected over UDP-Glc and UDP-GlcNAc since as high as 79 and 67% catalysis can be observed with UDP-Gal and UDP-GalNAc (versus only around 25-30% starting from their glucose counterparts). Enhanced catalysis of UDP-Gal versus UDP-GalNAc was observed at all enzyme dilutions and all time points tested ( Fig. S2 and S3 ). Therefore, we conclude OgcE is an epimerase with dual specificity for the interconversion of UDP-Gal/UDP-Glc and UDP-GlcNAc/UDP-GalNAc, with slightly higher efficiency for non-acetylated substrates.
Predicted function of the remaining genes in the ogc cluster. To gain clues on the function of the remaining ogc genes we investigated the glycosylation status of the DsbA1 derived peptide 23 VQTSVPADSAPAASAAAAPAGLVEGQN YTVLANPIPQQQAGK 64 in the various ogc gene deletion mutants. MS spectra of the DsbA1 derived peptide in K56-2, ΔpglL, ∆ogc, ∆ogcX, ∆ogcI, ∆ogcAB and ∆ogcE are shown in Fig. S4 . Using HCD fragmentation, four glycoforms of this peptide were identified, with all glycopeptides showing nearly identical peptide fragmentation maps (Fig. 6A ). The glycan attached to the four glycoforms corresponded to: HexNAc-HexNAc-Hex (Glycan A), HexNAc-HexNAc-262 (Glycan B), QuiNAc-Rha, and a single HexNAc (Fig.  6B ). The area under the curve of the extracted ion chromatograms for all observed glycoforms of the peptide enabled us to semi-quantitatively compared each state ( Fig. 6C and Table S2 ). The results show that glycoforms A and B were present in K56-2 with relative abundances of 44% and 52%, respectively, while the reminder 4% of the peptide was unmodified. In contrast, 100% and 84% of unmodified peptide was found in preparations obtained from ∆pglL and ∆ogc, respectively. The peak in ∆ogc with a relative abundance of 16% corresponded to a peptide modified by a glycan with the predicted mass of a QuiNAc-Rha disaccharide. As shown previously ( Fig. 4A ), deletion of the ogc cluster results in a truncated O antigen containing a terminal QuiNAc-Rha attached to the lipid A core (Fig. 4A, asterisk) . Therefore, we interpreted this result as due to the incorporation of the QuiNAc-Rha disaccharide, which is assembled as Und-PP-QuiNAc-Rha by the O antigen synthesis machinery and likely transferred to the target protein by PglL. In contrast, the ∆ogcI mutant lacked glycosylated peptides, as the glycan assembly is blocked at its initiation step ( Fig. 6C , Table S2 and Fig.  S4 ). Both ∆ogcX and ∆ogcAB showed predominantly unmodified peptide with 90% and 65 % relative abundance, respectively. The remainder glycosylated peptide in these 2 mutants corresponded to an HexNAc glycan form ( Fig. 6C , Table S2 and Fig. S4 ). The low abundance of a modified peptide with a single HexNAc in ∆ogcX, (9%) suggest the possibility that another flippase in the B. cenocepacia genome could mediate in part the membrane translocation of Und-PP-GalNAc (32) . A single ∆ogcB mutant also resulted in the production of HexNAc decorated glycoproteins as in ∆ogcAB, supporting the assignment of OgcB as the enzyme responsible for the addition of the second GalNAc ( Figure S5 ). Multiple attempts to delete ogcA were unsuccessful. It is possible that the absence of this gene may be deleterious for bacterial cell viability due to the accumulation of an Und-PP-linked GalNAc disaccharide that cannot be processed further, suggesting that OgcA is responsible for the addition of the terminal Gal and explaining why ∆ogc, ∆ogcAB, and ∆ogcB are well tolerated.
O-glycosylation is common in other Burkholderia species. The gene-by-gene conservation of the ogc cluster in the Burkholderia genus ( Fig. 1C ) suggests that protein glycosylation with β-Gal-(1®3)-α-GalNAc-(1®3)-β-GalNAc-(1® is widespread within Burkholderia species. We tested this idea in two ways. First, we showed that glycosylated proteins in lysates from B. cenocepacia, B. thailandensis and two different strains of B. gladioli can be detected using the peanut agglutinin ( Fig. S6 ). This lectin has specificity for Gal-β(1-3)-GalNAc terminal disaccharides. Second, bacterial glycopeptides were investigated by LC-MS in isolates representing several different Burkholderia species. Glycopeptides derived from five proteins were readily detectible from whole proteome samples of B. thailandensis E264 (Supplementary Data S1), such as the peptide 159 PAAASGAPAPAASGAAAH 176 of BTH_I3002ABC, which corresponds to the periplasmic substrate-binding protein of an ABC transporter ( Fig. 7 ) and is modified with the expected HexNAc-HexNAc-Hex. As with B. cenocepacia glycopeptides (21), we also noted the presence of HexNAc-HexNAc-262 and an additional modified glycan corresponding to HexNAc-HexNAc-362 in B. thailandensis (Supplementary Data S1). Examination of whole cell lysates from two clinical isolates of B. gladioli revealed at least 14 glycosylated proteins (Supplementary Data S2 and S3). The analysis of one of the glycosylated peptides, 594 AAHPGDIASEAAATGQPR 611 , of the B. gladioli bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III is shown in Fig. 7 . Analysis of eight clinical isolates of B. pseudomallei revealed three modified proteins, one of which was identified across all eight clinical isolates and corresponded to the known virulence factor Ecotin (33) ( Fig. 7 and Supplementary Data S4). As in the other cases, the B. pseudomallei glycopeptides were also modified with either HexNAc-HexNAc-Hex or HexNAc-HexNAc-262. Collectively, our results demonstrate that protein glycosylation occurs in Burkholderia species outside B. cenocepacia and that the addition of the HexNAc-HexNAc-Hex glycan appears to be an invariant feature across members of this genus.
Loss of O-glycosylation is associated to growth defects under many different carbon sources as well as oxidative and osmotic stress.
The conservation of the O-glycosylation pathway in the Burkholderia genus suggested it might be necessary for bacterial cell homeostasis. Therefore, we performed a global comparative analysis of carbon sources utilized by the K56-2 parental strain and ∆pglL using phenotypic microarrays (Biolog). The results show that ∆pglL utilized exogenous carbon sources less effectively than K56-2, especially sugar alcohols such as xylitol, monosaccharides (L-arabinose and D-mannose), deoxysugars (Lfucose and 2-deoxy-ribose), and various amino acids (D-alanine, L-alanine, D-serine, Larginine, L-lysine and L-ornithine) ( Fig. 8A and Supplementary Data S5). Also, ∆pglL could not utilize putrescine, which is produced from Lornithine by ornithine decarboxylase (BCAL2641 and BCAM1111) or from Larginine by arginine decarboxylase (BCAM1112) (34) . Further, ∆pglL grew poorly in media with tweens, formic acid, butyric acid, D-glucosaminic acid and D-galacturonic acid. A subset of significant phenotypic microarray differences resulting in growth defects relative to the parental strain were independently validated ( Fig. 8B ). We also examined the sensitivity of ∆pglL towards oxidative stress under a range of H2O2 concentrations. The results showed that the mutant has higher sensitivity towards H2O2 than K56-2 ( Fig.  S7A ). Because in long-term exposure experiments bacteria could adapt to H2O2 stress and since H2O2 is short-lived, we also performed a challenge experiment. In this case, bacteria were challenged with either 300 μM or 1 mM of H2O2 with bacterial inoculum of OD600 of 0.01 and 0.1 respectively for 1 h at 37°C. In both conditions, we found more than a 30% reduction in ∆pglL survival relative to K56-2 ( Fig. 7SB ). The ∆pglL mutant was also more susceptible to osmotic stress induced by high salt (4% NaCl) than K56-2 parental strain ( Fig.  S7C ). We also noted that the ∆pglL mutant was more proteolytically active than the parental strain ( Fig. 8C and D), a phenotype that was complemented by a plasmid carrying a functional pglL gene. Collectively, the results indicate that in the absence of protein glycosylation B. cenocepacia displays a global defect in utilization of multiple carbon sources, increased proteolytic activity, and reduced tolerance to stress conditions. We therefore conclude that the general protein Oglycosylation pathway may be important for the metabolic fitness of Burkholderia.
Loss of protein glycosylation reduces bacterial growth in the Galleria mellonella infection model and results in a rapid activation of the larval antimicrobial response. ∆pglL was previously reported to be avirulent in the wax moth G. mellonella and the duckweed Lemna minor, which are widely used insect and plant infection models, respectively, based on end-point experiments (21) . However, the mechanisms for the reduced virulence was not investigated. First, we compared the virulence of the O-glycan defective mutants and the bacterial loads recovered from the G. mellonella haemolymph over 72-h infections. Under our experimental conditions, the parental K56-2 strain caused death of all larvae at 48 h postinfection ( Fig. 9A ), while larvae infected with ∆pglL and ∆ogc had survival rates of 80% and 98%, respectively. We attributed the reduced virulence of ∆ogc (compared to ∆pglL) to the cumulative effect caused by the simultaneous loss of protein glycosylation and O antigen synthesis due to absence of ogcE in ∆ogc ( Fig. 4 ). Consistent with this, a strain in which ∆ogc was complemented by OgcE retained the same virulence level as ∆pglL at 48 and 72 h postinfection ( Fig. 9A ). Second, we examined whether decreased virulence is associated with poor growth of the Oglycosylation defective mutants in the infected larvae. Analysis of bacterial growth in larval haemolymph showed a 5-log increase in K56-2 (relative to the initial inoculum) at 48 h postinfection (p < 0.01; Fig. 9B ). In contrast, ∆pglL and ∆ogc bacteria only showed 2-log CFU increase at 48 h and ∆ogc demonstrated poorer growth overall compared to ∆pglL despite the differences were not statistically significant.
Third, we determined whether the significantly reduced virulence and in larvae growth of the O-glycosylation defective mutants correlated with rapid killing mediated by the G. mellonella's innate immune system. For this, we determined the expression pattern of innate immune genes in the infected larvae by RT-qPCR analysis. The results showed that the levels of cecropin and galliomycin transcripts were 6 to 11-, and 4-fold higher, respectively, in larvae infected with ∆pglL and ∆ogc than in those infected with K56-2 at 8 h postinfection (Fig. 9C ), while the levels of the galleriomycin transcripts did not differ at this time. By 18 h postinfection, the levels of cecropin and galleriomycin transcripts increased dramatically in larvae infected with the three strains, but the increased expression was more significant in larvae infected with K56-2. Lower levels of cecropin gene expression in Galleria infected with ∆ogc at 18 h could be related to the rapid death of bacterial cells. For galliomycin, the transcript levels did not increase much, although they were still significantly higher in larvae infected with ∆pglL and ∆ogc than in those infected with K56-2 ( Fig. 9C ). As infection in K56-2 was accompanied by increased pigmentation, we inferred the level of melanin formation by measuring the expression of the peptidoglycan recognition protein B (PGRP) gene. PGRP is a microbial pattern recognition molecule that recognizes bacterial cell fragments and mediates host responses towards bacterial infections through activation of prophenoloxidase cascade, responsible for melanization of pathogens and dead tissues, activation of Tol1 receptor and phagocytosis induction (35) . We found that the level of PGRP gene transcription was similar for larvae infected with the three strains at 8 h postinfection, but at 18 h the increase in PGRP gene expression was significantly higher in larvae infected with the parental strain than in those infected with the O-glycosylation mutants (Fig. 9C ). In contrast, transcript levels of the inducible metallo-protease inhibitor gene, which encodes a host inhibitor of bacterial proteases (36), remained similar but significantly higher in larvae infected with both K56-2 and ∆pglL than with ∆ogc. The expression of the gene encoding the cell wall degrading enzyme lysozyme (37) remained the similar in larvae infected with K56-2 or both Oglycosylation defective mutants, albeit their levels dramatically increased from 8 to 18 h postinfection. Collectively, these findings support the notion that the G. mellonella innate immune system responds early to infection by O-glycosylation defective bacteria, which compounded by reduced bacterial growth and reduced resistance to oxidative stress, could result in rapid and early killing of the mutant bacteria.
Burkholderia infected patients develop serum antibodies against the Burkholderia O-glycan. Given 10B ). This amounts to 86% of the tested serum samples giving positive reaction in the ELISA assay with glycosylated DsbA1. To confirm that the serum samples contained Burkholderia O-glycan specific antibodies, positive samples were adsorbed against glycosylated DsbA1 by serial passage on microtiter plates containing bound glycosylated protein and the adsorbed serum samples were then retested by ELISA. The results showed that all the originally positive samples became negative after adsorption ( Fig. 10B ). Together, the results reveal that the majority of the convalescent serum samples investigated had antibodies toward the Burkholderia glycan, indicating that either the glycan itself or the glycosylated proteins are antigens recognized upon human infection with Burkholderia species. Also, the results indicate that the antibodies recognize the glycoprotein made in B. cenocepacia irrespective of the type of infection cause, providing additional evidence that the infecting bacteria produce the same O-glycan.
DISCUSSION
In this study, we have uncovered the gene cluster encoding the enzymes responsible for the synthesis and assembly of the lipid-linked glycan precursor for the general protein Oglycosylation pathway in B. cenocepacia and also elucidated the glycan structure as the trisaccharide b-Gal-(1-3)-a-GalNAc-(1-3)-b-GalNAc-peptide. As previously reported (21), we found two forms of the O-glycan, one of which corresponds to a modified trisaccharide. Our data suggest that the trisaccharide core moiety of both glycans derives from the ogc pathway, while the modification likely involves non-stoichiometric succinylation at the terminal Gal residue. Succinylation appears as a variable modification in glycans from Rhizobium meliloti (38) and several other Proteobacteria (39) . Further studies are required to elucidate the structure of the modified glycan and identify the gene encoding the modifying enzyme.
Finding the ogc genes allowed us to predict gene functions, most of which were validated by single or double deletion mutagenesis followed by LC-MS analyses of the resulting glycopeptides. Thus, the OgcI protein was assigned as a member of the WecA family of phosphoglycosyltransferases, which catalyze the formation of undecaprenyldiphosphate sugars typically utilizing UDP-GlcNAc or UDP-GalNAc as nucleotide sugar substrates (24) . Our results support the assignment of OgcB as the glycosyltransferase adding the second GalNAc residue and predict OgcA is responsible for the addition of the terminal Gal. The inability to generate DogcA suggests that absence of this gene may be deleterious for bacterial cell viability. This interpretation is consistent with previous Tn-Seq analysis showing that insertions are unrepresented within the B. cenocepacia ogcA (40) and with a report indicating the B. pseudomallei K96243 ogcA homologue (BPSL2668) is essential for survival (41) . It is likely that without the terminal Gal the incomplete O-linked disaccharide glycan cannot be either effectively translocated across the membrane or processed by PglL, leading in both cases to the accumulation of Und-PP that cannot be recycled thus becoming growth limiting. Further experiments are required to confirm the function of OgcA.
Both the O-glycan and the O antigen in B. cenocepacia share GalNAc residues (25) . Therefore, the epimerization of UDP-Glc to form UDP-Gal would be needed for O-glycan synthesis. Our demonstration that the ogcE gene product catalyzes both reactions explains why the deletion of this gene results both in truncation of O-antigen and loss of protein glycosylation. This scenario is similar to that of C. jejuni GalE, which contributes to the biosynthesis of lipooligosaccharide, capsular polysaccharide, and N-linked glycosylation (42, 43) , and N. meningitidis GalE, which plays a role in pilin glycosylation and lipooligosaccharide synthesis (44) . A closer homologue of OgcE is the UDP-GalNAc-4epimerase of Yersinia enterocolitica, named Gne, which was reported to be specific for UDP-GalNAc with practically no activity on non-acetylated substrates (45) . However, we provide conclusive biochemical evidence that while B. cenocepacia OgcE has a slight preference for non-acetylated substrate UDP-Gal it can also interconvert UDP-GalNAc efficiently.
We also demonstrate that the general Oglycosylation pathway is a conserved feature of the Burkholderia genus. This conclusion is supported by multiple evidence. First, the ogc genes are conserved and collinear in most of the Burkholderia species for which genomic sequencing is available, with only few exceptions where some of genes were in different genomic locations. Second, analysis of the O-glycosylation glycoproteome in a subset of B. thailandensis, B. gladioli, and B. pseudomallei isolates confirms the production of a similar trisaccharide structure in these species. Third, B. cenocepacia, B. thailandensis and B. gladioli protein lysates reveal polypeptides that react with the peanut agglutinin, a lectin that recognizes Gal-β(1-3)-GalNAc terminal disaccharide of the O-glycan moiety.
The conservation of the glycosylation pathway in Burkholderia raises the question of the role of protein glycosylation in the biology of these bacteria, which despite their ability to cause infection in humans and certain domestic animals are also widespread in the environment (1) . We provide evidence that loss of protein glycosylation causes global metabolic defects in B. cenocepacia concerning the utilization of several different carbon sources and tolerance to osmotic and oxidative stress. Therefore, general protein O-glycosylation is required for metabolic fitness, possibly because it is involved in the stability of its protein targets, as shown in C. jejuni (46, 47) . We also found that not only are glycosylation defective mutants less virulent in the Galleria mellonella infection model, but also that the pathogen-host interaction at the cellular level is different. Indeed, the level of expression of antimicrobial peptides is higher and temporally faster in larvae infected with the glycosylation defective mutants. Delayed expression of antimicrobial peptides towards infection with the wildtype strain could be due to the rapid replication of the bacterium inside the infection model, suggesting that B. cenocepacia may need to reach certain threshold to cause overwhelming induction of G. mellonella immune response, which leads to larval death. This can also be explained by the higher sensitivity of ∆pglL to oxidative stress, which is also induced upon Galleria infection. Further, a relation between defective transporters and growth in invertebrate cells was demonstrated for Listeria monocytogenes implying that certain nutritional sources are also important substrates for bacterial growth in host cells (48) . Potentially, the ∆pglL defect in utilizing several carbon sources suggests that loss of glycosylation affects the function of proteins involved in nutrient transport across the periplasmic space, and could be another reason for the reduced virulence in G. mellonella. Therefore, loss of the general protein Oglycosylation system would make Burkholderia more susceptible to clearance by the host's innate immune, suggesting protein Oglycosylation could be considered as a novel target to develop inhibitors for possible clinical applications.
Another significant question arising from the conservation of the Burkholderia glycosylation pathway is whether Burkholderia glycoproteins are recognized by the human immune system. Burkholderia human infections represent a health risk to susceptible patient groups such as those with cystic fibrosis, as well as patients in endemic areas where B. pseudomallei prevails. Being multidrug resistant pathogens compounds this problem since Burkholderia infections are also difficult to treat (49) . We show that the vast majority of serum samples from cystic fibrosis patients infected with B. cenocepacia and B. multivorans, as well as from patients with melioidosis and glanders have antibodies that react with the O-glycosylated DsbA1 protein. This suggests that either the Burkholderia glycan or the combination of the glycan and the target protein at the glycosylation site are epitopes specifically recognized by the immune system, paving the way to future research to determine if these antibodies afford protection against infection.
In summary, this study has comprehensively characterized a conserved general protein O-glycosylation pathway in the Burkholderia genus demonstrating the relevance of protein glycosylation in the biology of B. cenocepacia and by extension in this group of bacteria widespread in multiple environmental niches and also responsible for opportunistic infections.
EXPERIMENTAL PROCEDURES
Strains and growth conditions. Strains and plasmids used in this study are listed in Table S3 . Bacteria were grown at 37°C in Luria-Bertani (LB) medium. Antibiotics were used at the following final concentrations: 50 μg trimethoprim ml -1 for E. coli and 100 μg ml -1 for B. cenocepacia, 30 μg tetracycline ml -1 for E. coli and 100 μg ml -1 for B. cenocepacia and 40 μg kanamycin ml -1 for E. coli. Ampicillin at 200 μg ml -1 and polymyxin at 20 µg ml -1 were used to select against donor and helper E. coli strains in triparental mating. Antibiotics and chemicals were purchased from Sigma-Aldrich (UK).
Recombinant DNA methods and deletion mutagenesis. The primers used are listed in Table 4 . DNA ligations, restriction endonuclease digestions, and agarose gel electrophoresis were performed according to standard techniques (50) or by Gibson assembly (51) . Restriction enzymes, Antarctic phosphatase and T4 DNA ligase were purchased from New England Bio labs (Ipswich, MA) and used as recommended by the manufacturer. E. coli GT115 and DH5α cells were transformed by the calcium chloride method (50) . PCR amplifications were carried out using the HotStar HiFidelity polymerase (Qiagen). Colony-PCR was performed with Taq polymerase (Qiagen). Amplifications reactions were optimized for each primer pair. DNA sequencing was performed at the sequencing facility in GATC Biotech (London, UK). Unmarked, non-polar gene deletion mutants were constructed as previously described (52) , and verified by DNA sequencing of PCR amplicons spanning the deletion endpoints.
Purification of BCAL2640. A plasmid constitutively expressing the BCAL2640 protein was constructed by amplifying the gene with primers Q539 and Q540. The resulting amplicon was digested with NdeI and XbaI and ligated into a similarly digested pDA12 resulting in pDA12-BCAL2640, which was introduced into K56-2 wild type, ∆pglL, and ∆ogc by triparental mating (52) . Exconjugants were isolated by plating on LB agar plates supplemented with 100 μg tetracycline ml -1 , 200 μg ampicillin ml -1 , 20 μg polymyxin ml -1 . Cultures of pDA12-BCAL2640 expressed in wild type, ∆pglL, or ∆ogc were grown overnight at 37 • C. Bacteria were harvested and lysed using a cell disrupter (Constant Systems Ltd., Northants, UK) at 18 kPsi. Supernatants containing soluble BCAL2640 protein were incubated with 0.2 M Ni 2+ -coated sepharose beads (GE Healthcare Life Sciences, UK) overnight at 4°C with mixing. The beads were washed and the His-tagged BCAL2640 was eluted twice with 250 mM imidazole. Purified BCAL2640 was run on 14% SDS-PAGE and stained by PageBlue Protein Staining Solution (Thermo Scientific, UK). Gel bands were excised and prepared for MS analysis.
Purification of DsbA1. Plasmid pMF22 (pMLBAD-DsbA1) was introduced into wild type B. cenocepacia K56-2, ∆pglL, ∆ogc, ∆ogcX, ∆ogcI, ∆ogcAB, ∆ogcE, and ∆BCAL3119-3131 by triparental mating (52) . Exconjugants were selected on LB agar plates supplemented with 100 μg trimethoprim ml -1 . For the purification of the lipoprotein DsbA1, stationary phase bacterial cultures were harvested at 12000 xg for 15 min at 4°C and resuspended in buffer A (1 μg ml −1 DNase I, complete EDTA-free protease inhibitor cocktail, 2% Triton X-114 in PBS). Bacteria were lysed with the cell disrupter, as described above. The supernatant was incubated at 37°C until phase separation was complete. The aqueous phase was removed after centrifugation at 10 000 xg for 10 min at 30°C. The remaining detergent layer containing the glycosylated lipoproteins was diluted to the original solution volume with buffer A without detergent for 1 h. Ten millimolar imidazole and 300 mM NaCl were added to the detergent phase prior to the addition of an appropriate volume of Ni 2+ coated sepharose beads equilibrated in buffer B (2% Triton X-114, and 30 mM NaCl in phosphate-buffered saline). This solution was allowed to mix overnight at 4°C. The beads were packed and then washed three times with buffer B containing 50 mM imidazole. The selected His-tagged DsbA1 was eluted twice, with two column volumes, with buffer B containing 300 mM imidazole. Purified DsbA1 was resolved on 14% SDS-PAGE and stained by PageBlue protein staining dye for MS analysis. Purified DsbA1 was either concentrated by TCA 10% precipitation overnight or passed on detergent removal spin column (ThermoScientific) prior to ELISA and NMR analysis respectively.
Protein manipulation and immunoblotting. Whole-cell lysates were prepared from overnight cultures of K56-2 and all mutants containing pAMF22 and induced by 0.2% arabinose overnight at 37 • C in the presence of 100 μg trimethoprim ml -1 . Two hundred μl of cells with O.D600 of 1 were pelleted, then resuspended in 1× sample buffer with 5% β-mercaptoethanol and boiled for 10 min. Protein separation was performed by 14% SDS-PAGE. His-tagged DsbA1 was revealed by immunoblotting using a 1:10,000 dilution of the mouse anti-His monoclonal antibody (GE Healthcare Life Sciences, UK). Proteins were visualized using a Licor Infrared Imaging System with Odyssey software. These experiments were replicated 3 times.
In-gel digestion of proteins. Gel separated proteins were processed as previously described (53) with minor modifications. Briefly, gel bands of interest were excised and destained in a 50:50 solution of 50 mM NH4HCO3 (pH 8.0) : 100% ethanol for 20 min at room temperature with shaking at 750 rpm. destained samples were then washed with 100% ethanol and vacuum-dried to dryness. Dried samples were then rehydrated in 10 mM DTT in 50 mM NH4HCO3 and reduced for 60 min at 56°C with shaking. Following reduction samples were washed twice in 100% ethanol for 10 min to ensure the complete removal of DTT and vacuum-dried to dryness. Reduced samples were rehydrated in 55 mM iodoacetamide in 50 mM NH4HCO3 in the dark for 45 min at room temperature. Following alkylation samples were washed twice with 100% ethanol and vacuum-dried. Dried alkylated samples were then rehydrated with 12 ng/µl trypsin (Promega, Madison WI) in 40 mM NH4HCO3 at 4°C for 1 h. Following rehydration excess trypsin was removed, gel pieces covered in 40 mM NH4HCO3 and incubated overnight at 37°C. Peptides samples were extracted from gel sample twice using four gel volumes of 30% ethanol 3% Acetic acid followed by four gel volumes of 100% ethanol with the supernatant from each extraction pooled. The resulting peptide mixtures were dried down, desalted using C18 stage tips (54) and stored on tip at 4°C. Peptides were eluted in Buffer B (80% acetonitrile, 0.1% Formic acid) and dried down before analysis by LC-MS.
Generation of whole cell lysates for proteome analysis. Burkholderia strains of interest were grown overnight on confluent LB plates. Plates were flooded with 5 mL of prechilled sterile phosphate-buffered saline (PBS) and colonies removed with a cell scraper. Cells were washed 3 times in PBS and collected by centrifugation at 10,000 x g at 4˚C then snap frozen. Frozen whole cell samples were resuspended in 4% SDS, 100mM Tris pH 8.0, 20mM DTT and boiled at 95˚C at 2000rpm for 10 min. Samples clarified by centrifugation at 17,000 xg for 10 min, supernatant collected and protein concentration determined by bicinchoninic acid assay (Thermo Scientific Pierce). 200ug of protein from each sample was acetone precipitated by mixing 4 volumes of ice-cold acetone with one volume of sample. Samples were precipitated overnight at -20˚C and then spun down at 16,000G for 10 min at 0˚C. The precipitated protein pellets were resuspended with 80% ice-cold acetone and precipitated for an additional 4 hours at -20˚C. Samples were centrifuged at 17,000 xg for 10 min at 0˚C, the supernatant was discarded and excess acetone driven off at 65 ˚C for 5 min.
Digestion of complex protein lysates. Dried protein pellets were resuspended in 6 M urea, 2 M thiourea, 40 mM NH4HCO3 and reduced / alkylated prior to digestion with Lys-C (1/200 w/w) and trypsin (1/50 w/w) overnight (55) . Digested samples were acidified to a final concentration of 0.5% formic acid and desalted with home-made highcapacity StageTips composed on 5mg Empore™ C18 material (3M, Maplewood, Minnesota) and 5mg of OLIGO R3 reverse phase resin (Thermo Fisher Scientific) according to the protocols of Ishihama and Rappsilber (56, 57) . Bound peptides were eluted with buffer B, dried and stored at -20 ˚C.
Liquid Chromatography and Mass Spectrometry analysis.
Prior to LC-MS analysis, samples were re-suspended in 15 µL Buffer A (2% acetonitrile, 0.1% Formic acid). LC-MS was performed on either an Agilent 1290 Series HPLC (Agilent Technologies, Mississauga, ON) coupled to LTQ-Orbitrap Velos (Thermo Scientific, San Jose CA), a Dionex Ultimate 3000 UPLC (Thermo Scientific) coupled to an Orbitrap Elite or an EASY-nLC1000 system coupled to a Q-Exactive. For the LTQ-Orbitrap Velos and Q-Exactive, LC-MS was accomplished using a two column system in which samples were concentrated prior to separation on a 2-cmlong, 100-μm-inner diameter fused silica trap column containing 5.0-μm Aqua C-18 beads (Phenomenex) and then separated using an inhouse packed C18 analytical 75 µm inner diameter, 360 μm outer diameter column composed of 35 cm ReproSil-Pur C18 AQ 1.9 μm (Dr. Maisch, Ammerbuch-Entringen, Germany) column for the EASY-nLC1000 system or a 20cm ReproSil-Pur C18 AQ 3.0 µm for the Agilent 1290 Series HPLC. Samples were concentrated onto the trap for 10 min using 100% Buffer A at 5µl/min after which the gradient was altered from 100% phase A to 40% Buffer B over 90 min at 250 nl/min with the eluting peptides infused directly into the mass spectrometers via nESI. For the Orbitrap Elite LC-MS was accomplished using a twocolumn chromatography set up comprising a PepMap100 C18 20 mm x 75 μm trap and a PepMap C18 500 mm x 75 μm analytical column (Thermo Scientific). Samples were concentrated onto the trap column at 5 μl/min for 5 mins and infused into an Orbitrap Elite at 300 nl/min via the analytical column. One hundred and 80-min gradients were run altering the buffer composition from 1% buffer B to 28% B over 145 mins, then from 28% B to 40% B over 10 mins, then from 40% B to 100% B over 2 mins, the composition was held at 100% B for 3 mins, and then dropped to 3% B over 5 mins and held at 3% B for another 15 mins. All instruments were operated in a data-dependent manner using Xcalibur v2.2 (Thermo Scientific). For samples analyzed on the LTQ-Velos, one full precursor scan in the Orbitrap (resolution 60,000; 500-2,000 Th, AGC target of 1 × 10 6 ) was followed by the selection of the top four most intense, multiply charged ions above 5000 counts for collision-induced dissociation (CID, normalized collision energy 35, AGC of 4 × 10 4 ) followed by higher energy collisional activated dissociation (HCD, resolution 7500, normalized collision energy 40, ACG of 2 x 10 5 ) with 30 s dynamic exclusion enabled as previously described (55) . For samples analyzed on the Orbitrap Elite, one full precursor scan in the Orbitrap (resolution 60,000; 500-2,000 Th, AGC target of 1 × 10 6 ) was followed by the selection of the five four most intense, multiply charged ions above 10000 counts for collision-induced dissociation (CID, normalized collision energy 35, AGC of 4 × 10 4 ) followed by higher energy collisional activated dissociation (HCD, resolution 15000, normalized collision energy 40, ACG of 2 x 10 5 ) with 45 s dynamic exclusion enabled. For samples analyzed on the Q-Exactive, one full precursor scan (resolution 70,000; 350-2,000 m/z, AGC target of 3 × 10 6 ) was followed by 10 data-dependent HCD MS-MS events (resolution 35k, normalized collision energy of 25 with 50% stepping, AGC target of 1 × 10 6 ) with 25 s dynamic exclusion enabled. Area of the most intense charge state of each species was used to assess the relative levels / distribution of observed peptides.
Glycopeptide identification. Raw data files were processed with Proteome Discover version 1.4 (Thermo Scientific) to generate mgf files. The resulting mgf files were searched using MASCOT v2.4 (Matrix Science, provided by the BC Proteomics Network http://www.proteincentre.com/mascot/). Searches were carried out using semi-trypsin specificity, carbamidomethylation of cysteine as a fixed modification and Oxidation (M) as a variable modification. A precursor and product tolerance of 20ppm was used and B. cenocepacia data searched against the B. cenocepacia K56-2Valvano proteome (http://www.uniprot.org/taxonomy/985076, downloaded from NCBI February 15 th 2013), while non-B. cenocepacia species were searched against the NCBI proteome database (Downloaded 1 st of September 2016) with the taxonomy restricted to "Other Proteobacteria". Scan events that did not result in peptide identification were manually inspected and identified as possible glycopeptides based on the presence of the diagnostic oxonium ion 204.09 m/z of HexNAc or 188.09 m/z in the case of QuiNAc modified peptides. To facilitate glycopeptide assignments from HCD scans, the ions below the mass of the predicted deglycosylated peptides were extracted with Xcalibur v2.2 using the Spectrum list function. Ions with a deconvoluted mass above that of the deglycosylated peptide and ions corresponding to known carbohydrate oxoniums were removed in a similar approach to post-spectral processing of ETD data (58) and searched as above with mascot. All spectra were searched with the decoy option enabled with all peptides passing a 1% FDR. Identified glycopeptide spectra were manually inspected and spectra annotated according to the nomenclature of Roepstorff and Fohlman (59) (Supplementary Data S1-S4). Glycopeptides derived from clinical Burkholderia strains were matched to either the B. gladioli reference strain BSR3 or the B. pseudomallei reference strain K96243.
Structural characterization of the protein glycan moiety. DsbA1, that was heterologously expressed in B. cenocepacia, obtained from TCA precipitation was dissolved in water (1 ml), and two aliquots of Proteinase K (0.3 mg each, Sigma P-2308) were added at 37°C, at 8 h interval, with last addition left overnight. The solution was directly loaded on a column packed with Bio-Gel P10 (d = 1.5 cm, h = 118 cm) using water as eluent (flow = 16 ml/h) and monitoring the eluate with a refractive index detector (Knauer K-2301). Fractions were pooled and monitored by 1 H NMR and the fraction enriched in the glycopeptide was eluted after approx. 40% of the total column volume. NMR analyses were performed on a Bruker 600 MHz equipped with a cryo-probe. Spectra were recorded at 15°C using acetone as internal standard ( 1 H 2.225 ppm, 1 3 C 31.45 ppm). 2D spectra (DQF-COSY, TOCSY, TROESY, and gHSQC) were recorded using Bruker software (TopSpin 2.1). Homonuclear experiments were recorded using 512 FIDs of 2048 complex with 40 scans per FID, for TOCSY and TROESY spectra a mixing time of 100 and 300 ms was applied, respectively. HSQC spectrum was acquired with 512 FIDs of 2048 complex point and 60 scans per FID; spectra were processed and analyzed using Bruker TopSpin 3 program.
Extraction and analysis of B. cenocepacia lipopolysaccharide. Proteinase K-treated whole cell lysates were resolved by SDS-PAGE (16% v/v polyacrylamide) and visualized following silver staining (60) . Complementation of O-antigen synthesis in ∆ogc was done by conjugating pXO23 (pAP20::ogcE) into the mutant by triparental mating and exconjugants were counterselected on 100 μg chloramphenicol ml -1 , 200 μg ampicillin ml -1 and 20 μg polymyxin ml -1 .
OgcE enzymatic assay. BCAL3117 was amplified by primers Q729 and Q728, cut by restriction enzymes NdeI and EcoRI and cloned in pET28 vector containing an N-terminal 6x His-tag that had been cut with the same restriction enzymes. Expression was induced by IPTG 0.5 mM for 3 h at 37°C for a 300 ml culture. The cells were harvested by centrifugation and lysed by passage in a cell disruptor after resuspension in buffer A: 50 mM Tris-HCl, 100 mM NaCl. OgcE was purified using a 3 ml Fast Flow chelating Sepharose column loaded with Ni 2+ and equilibrated in buffer A. After extensive washing with buffer A, OgcE was eluted with increasing concentrations of imidazole (100-400 mM). The purified enzyme was preserved by addition of glycerol (25% final concentration) and frozen at - (61) . The % of conversion was obtained by integrating the substrate and product peak surface areas using the 32Karat software.
Oxidative and osmolar susceptibility testing.
Sensitivity towards different concentrations of hydrogen peroxide (Sigma) was assessed using the bioscreen. Bacterial cultures were diluted to an OD600 of 0.01 in LB and dispensed in 100-well plates in 270 µl volumes. 30 ml aliquots of hydrogen peroxide in different concentrations were added to the bacterial cultures. Plates were incubated in a Bioscreen C automated growth curve reader for 16 h with OD600 readings taken every 1 h. The same procedure was employed to determine the susceptibility towards high concentrations of NaCl using glucose as a carbon source.
Survival assay was also made after challenging bacterial cultures in LB with hydrogen peroxide at concentrations of either 300 μM with bacterial inoculum of 8x10 6 cfu/ml or 1 mM with bacterial inoculum of 8x10 7 for 1 h at 37ºC with shaking. Samples were withdrawn and serially diluted in PBS. Then, 10 μl portions were dropped onto the surface of LB agar plates. The plates were incubated at 37ºC for 24 h, the resulting colonies were counted and the % of survival was determined relative to parallel-untreated control samples.
Phenotypic microarray experiments. The metabolic phenome of B. cenocepacia K56-2 and ∆pglL was assessed using preconfigure Biolog Phenotype MicroArrays (PMs) from Biolog Inc., Hayward, CA, USA. We used PM plates 1 and 2, which contain 190 of the most common carbon sources in 96-well arrangements composed of one negative control well and 95 wells prefilled with a given carbon source in a dried state. PM experiments were performed following the standard protocol (62) . Briefly, B. cenocepacia strains were grown on LB agar plates for 36 h at 37ºC. A cell suspension of 95 % transmittance in Biolog solution IF-0 was prepared by resuspending bacteria grown on LB agar plates. Dye A was then added and then 100 μl/well were transferred to each of the 96-well PM microplates (a set of 95 substrates and one blank well). The plates were incubated at 37 °C for 48 h. The optical density (OD600) values were then measured using microtiter plate reader. Each experiment was performed as biological duplicates and growth differences were established by comparing the area under the growth curve (AUC). Growth in a given carbon source was considered positive when median AUC was more than 40% higher than negative control AUC. A cut-off value of 80% was used to determine a significant growth reduction of the mutant compared to wildtype. Hits ranged from reduction in growth from 80% up to less than 60% (Fig. 8A) . Positive results were subsequently validated by the performing growth studies using the automated Bioscreen C in M9 minimal media to test the utilization of selected carbon sources compared to PM1 and PM2 plates. Bacterial cultures were diluted to approximately an OD600 of 0.01 in M9 minimal media deprived of carbon sources and dispensed in 100-well plates in 270 µl volumes. Each required carbon source was tested individually by adding 30 µl of a stock solution to each to the 100-well Bioscreen plate to give final concentrations of 0.2% (W/V) in the wells. Plates were incubated in a Bioscreen C automated growth curve analyser for 48 h and bacterial growth was assessed turbidimetrically at 600 nm every 2 h. Comparisons were also made by determining the AUC obtained over 4 biological replicas in triplicate.
Proteolytic activity. To determine protease activity, overnight cultures grown in LB were diluted to an OD600 of 1, and 3 μl of this culture was spotted onto a nutrient agar plate containing 1.5% skim milk (63) . The plates were incubated for 48 h at 37°C, after which the radii of the cleared zones surrounding the colonies were measured.
Galleria mellonella larvae Infection. G. mellonella wax moth larvae were acquired from UK Waxworms Ltd. and stored in wood shavings in the dark at 16 °C prior to infection. Larvae of approximate weight of 250 to 350 mg were used. Bacteria were grown in 5 ml LB, harvested during exponential phase, resuspended in sterile PBS and serially diluted. The surface of the larvae was disinfected by ethanol (70%) and then larvae were injected with 10 μl of bacterial suspension, containing approximately 8x10 4 CFU/ml of either K56-2 or the tested mutants, into the last right proleg by use of a Hamilton syringe with a 26-gauge needle. A group of 10 control larvae were injected with 10 μl of PBS in parallel. Larvae were kept at 37°C in the dark. Larval survival was monitored at 24 h intervals over a period of 72 h and was judged based on visual appearance and lack of movement in response to stimuli. Three independent experiments were performed.
Determination of in vivo bacterial loads in G. mellonella. Larvae were infected with approximately 8 x 10 4 CFU of K56-2 or ∆pglL or ∆ogc. Groups of three insects were collected at 24 h and 48 h, and hemolymph samples from 3 larvae (approximately 100 μl) were collected in microcentrifuge tubes containing 10 μl of a saturated solution of N-phenylthiourea (Sigma-Aldrich, UK). Serial dilutions of the homogenate in PBS were plated on LB agar supplemented with spectinomycin 100 μg ml -1 , and colonies were counted after incubation at 37°C for 24 h. Three independent experiments were performed. No CFU were recovered from non-infected larvae in LB agar supplemented with spectinomycin.
RNA extraction and RT-PCR. Larvae were infected with approximately 1 x 10 4 CFU of exponentially growing bacterial cultures. At 8 h and 18 h post infection, 3 larvae from either the control PBS group or the infected group were homogenized on ice with 1ml of Trireagent (Ambion), using Stuart homogenizer SHM2
(Bibby Scientific Limited, Staffordshire, UK). Total RNA was purified by a standard chloroform-isopropyl alcohol protocol, and the obtained RNA was further purified using a Nucleospin RNAII kit (Macherey-Nagel) that included one step of oncolumn DNAse treatment, following the manufacturer's instructions. The quantification of purified RNA samples was performed with a nanodrop (Nanovue Plus, GE Healthcare). cDNA was obtained from 1 μg total RNA by using a commercial Moloney murine leukaemia virus (M-MLV) reverse transcriptase (Invitrogen, UK). Real-time PCR (RT-PCR) analyses were performed with a Mx3005p qPCR system (Agilent Technologies, UK). One hundred nanograms of cDNA were used as the template in a 20-μl reaction mixture containing KapaSYBR Fast qPCR mix (Kapa Biosystems) and primer mix. Actin and 18S rRNA genes were amplified as housekeeping genes. The primers used are listed in Table S1 . The thermocycling protocol was as follows: 95°C for 3 min for hot-start polymerase activation, followed by 45 cycles of denaturation at 95°C for 15 s and annealing at 60°C for 30 s. SYBR green dye fluorescence was measured at 521 nm during the annealing phase. Fold changes in gene expression were calculated using the Livak method (∆∆CT) (64) with normalization to the actin gene (Supplementary Data S6).
ELISA. Antibodies against glycosylated and unglycosylated DsbA1 were detected by indirect ELISA. Ninety-six well Nunc MaxiSorp plates were coated with 50 μl of purified DsbA1 protein expressed in K56-2 WT (glycosylated) or in ∆pglL (non-glycosylated) and diluted in coating buffer (carbonate/bicarbonate, 100 mM, pH 9.6) to reach a final concentration of 2-4 μg/ml. Control wells contained only coating buffer. The plates were covered by plastic adhesive film and incubated at 4°C overnight. Coating solution was removed and plates were washed with 300 μl PBS/Tween20 (0.05%). Additional blocking was achieved by adding 300 μl of blocking buffer (BSA 5%). Plates were covered and incubated at room temperature for 1 h and then washed 3 times with PBS/Tween20. Fifty microliters of serum samples, diluted in halfstrength blocking buffer, were added to the wells and incubated for 90 min at room temperature. Normal human serum from non-infected individuals was used as a negative control. Plates were washed 4 times with PBS/Tween20. Fifty microliters of biotinylated rabbit anti-human IgG secondary antibody diluted to 1:20000 (1 μl in 20 ml PBS) were added and incubated for 1 h at room temperature. Plates were washed 5 times with PBS/Tween20. Fifty microliters of Streptavidin-Horseradish Peroxidase diluted 1:300 in PBS were then added to the wells and incubated for 1 h in dark at room temperature. After washing 4 times with PBS/Tween20, 50 μl of the substrate solution 3,3',5,5'tetramethylbenzidine were added per well and incubated in the dark at room temperature. After sufficient color development, 30 μl of stop solution (3M HCl) were added and the absorbance of each well was read with POLARstar Omega microplate reader (BMG LABTECH, Ortenberg, Germany) at 450nm. Three independent repeats were made for every sample, each done in duplicate. A positive ELISA test was defined by an absorbance reading exceeding the cut-off value computed by two standard deviations above the mean of the negative control. We also performed a confirmatory reverse ELISA was done, in which the glycan specific antibodies from positive serum samples were adsorbed using the glycosylated DsbA1 protein by incubating the samples with the glycosylated protein at a concentration of 100 µg/ml for 2 h at room temperature and overnight at 4°C for 3 successive passages. Serum samples were then collected and used in a normal ELISA procedure as described above in parallel to the same samples without adsorption. Results are presented in ELISA units in which a cut-off of 2X standard deviation of the mean of the negative control was used to decide whether a serum sample is reactive towards the glycan or not.
Ethics (BCAL3114-BCAL3118) , placed between the O-antigen and lipid Acore clusters. Names of ORFs indicated above the arrows are according to the original gene annotation (25) . Names below are the ones assigned in the current study. B, proposed model for the general Oglycosylation assembly pathway in B. cenocepacia; OgcI: initiating enzyme, OgcE: UDPglucose/galactose epimerase, OgcAB: glycosyltransferases, OgcX: flippase, and PglL: oligosaccharyltransferase. C, synteny of ogc genes in members of the Burkholderia genus. Genes indicated in bold are the ones used to search for synteny in the SyntTax server. The species showing similar arrangements are listed for each group. The synteny scores ranged from 55 to 96 (>30 is considered highly significant conservation) (26) . D, relative gel mobility of BCAL2640 and DsbA1 polypeptides in ∆ogcX-ogcI and single deletion mutants. Similar results were obtained in 3 biological repeats. Left panel: Coomassie-stained 14% SDS-polyacrylamide gel of the purified B. cenocepacia BCAL2640 protein expressed in wildtype K56-2, ∆pglL, and ∆ogc. Right panel Western blot of Histagged DsbA1 acceptor protein expressed in the parental K56-2 strains and the mutants ∆pglL, ∆ogcX, ∆ogcX, ∆ogcI, ∆ogcAB, ∆ogcE and ∆O-antigen cluster (∆BCAL3119-BCAL3131). non-glycosylated forms of 152 YAPPPAAVPVAATSGAQGGAAAAAAPAGTKPANAPR 187 . In K56-2 (wildtype), the BCAL2640 glycosylated peptide was >15-fold more abundant than the unglycosylated form. This peptide was not glycosylated in ΔpglL or ΔogcX-ogcI. *denotes deglycosylated peptide resulting from in-source fragmentation. FIGURE 3. NMR spectra of the glycopeptide. Representative regions of the NMR spectrum acquired at 600 MHz spectrometer, in D2O at 15°C, for the glycopeptides from DsbA1 after Proteinase K digestion and chromatographic purification. A, zoom of 1 H NMR spectrum in the ring proton region, B, multiplicity edited 1 H-13 C HSQC spectrum with signals in grey represent methylene carbon atoms; the inset shows a zoom of the downfield region with the three anomeric resonances of A-C residues. C, superimposition of 1 H-1 H TOCSY (grey) and 1 H-1 H T-ROESY (black) spectra. Attribution of most relevant cross peaks is indicated nearby the corresponding density, and labels reflect those reported in Table S1 . The structure of the glycopeptide's glycan moiety, along with the labels used during spectra attribution, is shown as well panel B. Unattributed peaks are related to peptides signals. Activity assessment and peak assignments were also based on optimization at different enzyme / substrate ratios and various reaction times, and based on co-injections with standards. Glycopeptides detected in B. thailandensis, B. gladioli, and B. A, heat map for carbon source phenotypes as determined by phenotypic microarrays using an Omnilog system (see Materials and Methods). Yellow represents wildtype growth. Blue shading denotes ranges of growth below 80% of the wildtype growth in the same carbon source, calculated by comparing the area under curve of wildtype and mutant strain (AUC). The complete results for all carbon sources tested are presented in Supplementary Data S5 . B, selective carbon sources giving differences between K56-2 and ∆pglL were independently validated by generating growth curves measured by the automated bioscreen C using M9 minimal medium with the relevant carbon source under investigation. Statistical differences (mean ± standard deviation) of the area under each growth curve were analyzed by multiple t-test comparisons with confidence interval of 95%. n=4 per carbon source. *, p = 0.02; **, p < 0.01; ***, p < 0.001. C, casein proteolytic activity of K56-2, ∆pglL, and the complemented mutant (∆pglL + PglL) was assayed casein-containing nutrient agar plates. Plates shown are representatives of at least 2 experiments done in triplicates. D, quantification of the data in C by measuring the clear halo around the colonies after incubation at 37°C for 48 h. Values are expressed as mean ± standard deviation in millimetres. Statistical differences were analyzed by one-way ANOVA with Tukey's multiple comparisons tests; α = 0.01; ***, p < 0.0001.
FIGURE 9. Role of O-glycosylation in bacterial proliferation and G. mellonella larval mortality.
A, larvae were injected with 8x10 4 CFU of parental and mutant strains and the percent survival was monitored over 72 h postinfection. Statistical differences (means ± standard deviations) were examined by 2-way ANOVA with Tukey's multiple comparisons tests; a=0.05. B, hemolymph from B. cenocepacia-infected larvae (n=3) was pooled and CFU were determined by viable count. Results are presented as a superimposed scatter plot and statistical differences (means ± standard deviations) were examined by 2-way ANOVA as indicated above. C, transcriptional activation of immune-responsive genes following infection determined by quantitative real-time RT-PCR analysis. The graphs show the normalized fold expression levels of the target transcripts relative to those in PBS-injected animals, and represent means ± standard deviations of 3 independent experiments, each with two technical replicas. Expression data were normalized to the expression of the housekeeping actin gene. PGRP, Peptidoglycan recognition protein; IMPI, inducible metallo-protease inhibitor. Data were statistically analyzed by two-way ANOVA with Tukey's multiple comparisons tests and a=0.05. ns, nonsignificant. The calculated p values from individual comparisons are indicated in the figure. . cenocepacia, B. multivorans, B. mallei, and B. pseudomallei. Non-glycosylated heterologouslyexpressed DsbA1 protein in ∆pglL was used in the experiment. Thin arrows point at the serum samples that reacted with both glycosylated and unglycosylated DsbA1 heterologously expressed in K56-2 and ∆pglL, respectively. Three independent experiments were done, each in duplicate. Thick arrows point at the serum samples that gave negative results with glycosylated DsbA1. B, serum samples were adsorbed by incubation with the glycosylated DsbA1 protein for 3 successive passages prior to ELISA. Two independent experiments were done. Dotted blue lines in A and B indicate the negative cut-off OD450 value for background color in the ELISA determined by running ELISA assays in normal human serum from 30 donors. Error bars represent standard deviation of the mean. 
